BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11877310)

  • 1. Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia.
    Tobin G; Thunberg U; Johnson A; Thörn I; Söderberg O; Hultdin M; Botling J; Enblad G; Sällström J; Sundström C; Roos G; Rosenquist R
    Blood; 2002 Mar; 99(6):2262-4. PubMed ID: 11877310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunoglobulin genes and chronic lymphocytic leukemia (CLL).
    Tobin G
    Ups J Med Sci; 2005; 110(2):97-113. PubMed ID: 16075892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope.
    Tobin G; Thunberg U; Johnson A; Eriksson I; Söderberg O; Karlsson K; Merup M; Juliusson G; Vilpo J; Enblad G; Sundström C; Roos G; Rosenquist R
    Blood; 2003 Jun; 101(12):4952-7. PubMed ID: 12586612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin mutational status detected through single-round amplification of partial V(H) region represents a good prognostic marker for clinical outcome in chronic lymphocytic leukemia.
    Marasca R; Maffei R; Morselli M; Zucchini P; Castelli I; Martinelli S; Fontana M; Ravanetti S; Curotti M; Leonardi G; Cagossi K; Partesotti G; Torelli G
    J Mol Diagn; 2005 Nov; 7(5):566-74. PubMed ID: 16258154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the current evidence for antigen involvement in the development of chronic lymphocytic leukemia?
    Tobin G; Rosén A; Rosenquist R
    Hematol Oncol; 2006 Mar; 24(1):7-13. PubMed ID: 16315334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins.
    Widhopf GF; Rassenti LZ; Toy TL; Gribben JG; Wierda WG; Kipps TJ
    Blood; 2004 Oct; 104(8):2499-504. PubMed ID: 15217828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.
    Hamblin TJ; Davis Z; Gardiner A; Oscier DG; Stevenson FK
    Blood; 1999 Sep; 94(6):1848-54. PubMed ID: 10477713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of biased immunoglobulin variable gene usage in highly stable B-cell chronic lymphocytic leukemia.
    Capello D; Guarini A; Berra E; Mauro FR; Rossi D; Ghia E; Cerri M; Logan J; Foà R; Gaidano G
    Leukemia; 2004 Dec; 18(12):1941-7. PubMed ID: 15483675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mutation of bcl-6 genes can occur in the absence of V(H) mutations in chronic lymphocytic leukemia.
    Sahota SS; Davis Z; Hamblin TJ; Stevenson FK
    Blood; 2000 Jun; 95(11):3534-40. PubMed ID: 10828040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.
    Damle RN; Wasil T; Fais F; Ghiotto F; Valetto A; Allen SL; Buchbinder A; Budman D; Dittmar K; Kolitz J; Lichtman SM; Schulman P; Vinciguerra VP; Rai KR; Ferrarini M; Chiorazzi N
    Blood; 1999 Sep; 94(6):1840-7. PubMed ID: 10477712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications.
    Hultdin M; Rosenquist R; Thunberg U; Tobin G; Norrback KF; Johnson A; Sundström C; Roos G
    Br J Cancer; 2003 Feb; 88(4):593-8. PubMed ID: 12592375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.
    Rassenti LZ; Huynh L; Toy TL; Chen L; Keating MJ; Gribben JG; Neuberg DS; Flinn IW; Rai KR; Byrd JC; Kay NE; Greaves A; Weiss A; Kipps TJ
    N Engl J Med; 2004 Aug; 351(9):893-901. PubMed ID: 15329427
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Maity PC; Bilal M; Koning MT; Young M; van Bergen CAM; Renna V; Nicolò A; Datta M; Gentner-Göbel E; Barendse RS; Somers SF; de Groen RAL; Vermaat JSP; Steinbrecher D; Schneider C; Tausch E; Bittolo T; Bomben R; Mazzarello AN; Del Poeta G; Kroes WGM; van Wezel JT; Imkeller K; Busse CE; Degano M; Bakchoul T; Schulz AR; Mei H; Ghia P; Kotta K; Stamatopoulos K; Wardemann H; Zucchetto A; Chiorazzi N; Gattei V; Stilgenbauer S; Veelken H; Jumaa H
    Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4320-4327. PubMed ID: 32047037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL-6 mutations are associated with immunoglobulin variable heavy chain mutations in B-cell chronic lymphocytic leukemia.
    Pasqualucci L; Neri A; Baldini L; Dalla-Favera R; Migliazza A
    Cancer Res; 2000 Oct; 60(20):5644-8. PubMed ID: 11059755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene.
    Ghia P; Stamatopoulos K; Belessi C; Moreno C; Stella S; Guida G; Michel A; Crespo M; Laoutaris N; Montserrat E; Anagnostopoulos A; Dighiero G; Fassas A; Caligaris-Cappio F; Davi F
    Blood; 2005 Feb; 105(4):1678-85. PubMed ID: 15466924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern and distribution of immunoglobulin VH gene usage in a cohort of B-CLL patients from a Northeastern region of Italy.
    Donisi PM; Di Lorenzo N; Riccardi M; Paparella A; Sarpellon C; Zupo S; Bertoldero G; Minotto C; Stracca-Pansa V
    Diagn Mol Pathol; 2006 Dec; 15(4):206-15. PubMed ID: 17122648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia.
    Mauerer K; Zahrieh D; Gorgun G; Li A; Zhou J; Ansén S; Rassenti LZ; Gribben JG
    Br J Haematol; 2005 May; 129(4):499-510. PubMed ID: 15877732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. V(H)3-21 gene usage in chronic lymphocytic leukemia--characterization of a new subgroup with distinct molecular features and poor survival.
    Tobin G; Söderberg O; Thunberg U; Rosenquist R
    Leuk Lymphoma; 2004 Feb; 45(2):221-8. PubMed ID: 15101705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of intraclonal diversification in Ig heavy and light chain V region genes expressed by CD5+IgM+ chronic lymphocytic leukemia B cells: a multiple time point analysis.
    Schettino EW; Cerutti A; Chiorazzi N; Casali P
    J Immunol; 1998 Jan; 160(2):820-30. PubMed ID: 9551917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal B cells express 51p1-encoded Ig heavy chains that are distinct from those expressed by chronic lymphocytic leukemia B cells.
    Widhopf GF; Kipps TJ
    J Immunol; 2001 Jan; 166(1):95-102. PubMed ID: 11123281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.